Figure (Teri Um Arrow V1)
Teriparatide Injection, Solution
Product Images NDC 66993-495
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 66993-495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Teri Um F01 V1)
An illustration diagram labeling parts of a Teriparatide delivery device for subcutaneous injection. It shows components including the black injection button, yellow shaft, red stripe, blue body, label, medicine cartridge, white cap, paper tab, needle, small needle protector, and large needle cover. A note states needles are not included and recommends Becton, Dickinson and Company pen needles for use.*
Figure (Teri Um F02 V1)
An instructional illustration showing hands twisting the cap off a pen injector device. The image likely relates to preparing the device for a subcutaneous injection, such as with Teriparatide injection solution 250 mcg/mL.*
Figure (Teri Um F03 V1)
An instructional illustration showing two hands preparing a prefilled injection device by removing or attaching the protective cap from the needle end, associated with Teriparatide 250 mcg/mL subcutaneous injection solution.*
Figure (Teri Um F04 V1)
An instructional illustration showing a person holding a Teriparatide injection pen with one hand while using the other hand to remove the protective cap from the needle. The diagram highlights the preparation step for subcutaneous injection of Teriparatide solution.*
Figure (Teri Um F05 V1)
An instructional illustration showing hands preparing a Teriparatide injection. The image depicts how to manipulate the injection device with a rotating motion, likely indicating the step to remove or adjust the needle protective cap for subcutaneous administration.*
Figure (Teri Um F06 V1)
An instructional illustration showing a close-up of a syringe with a large needle cover being removed by a hand, related to the administration of Teriparatide injection, solution, subcutaneous dosage form.*
Figure (Teri Um F07 V1)
An instructional illustration showing hands preparing a medication pen injection. One hand grips the pen while the other hand removes the pen cap by pulling it downward, indicated by a black arrow below the cap.*
Figure (Teri Um F08 V1)
An instructional illustration showing a hand holding a vial with a red stripe, highlighting the vial's identification feature. The image is likely part of usage or safety instructions for Teriparatide injection, solution 250 mcg/mL by Prasco Laboratories.*
Figure (Teri Um F09 V1)
An instructional illustration showing a hand removing a small needle protector from a syringe or injection pen, highlighting the step before administration of an injection.*
Figure (Teri Um F10 V1)
An instructional illustration showing a person administering a subcutaneous injection with an auto-injector device into the abdominal area. The image demonstrates the proper hand positioning and injection site for the injection.*
Figure (Teri Um F11 V1)
An instructional illustration depicting self-administration of a subcutaneous injection using a pen device. The illustration shows a hand holding the pen injector against the abdomen, with a countdown from 1 to 5 indicating the injection process.*
Figure (Teri Um F12 V1)
An instructional illustration showing a close-up of a hand holding a pen-like device with a blue button or cap at the top, highlighted by a blue circle. The image likely demonstrates part of the usage or administration process for a subcutaneous injection device.*
Figure (Teri Um F13 V1)
An instructional illustration showing a hand gripping a device (possibly an injection pen) with a red prohibition symbol overlay, indicating an action not to be performed with this grip or device. No text or product information is visible.*
Figure (Teri Um F14 V1)
An instructional illustration showing a hand holding a Teriparatide injection pen with the large needle cover being removed or detached. The image visually directs the user on how to prepare the injection device for use.*
Figure (Teri Um F15 V1)
An instructional illustration showing hands operating a pen-style injection device. The right hand is twisting the orange cap off the device, indicated by a red circular arrow demonstrating the removal motion. This image depicts preparation steps for using a subcutaneous injection pen, such as that used for Teriparatide 250 mcg/mL injection solution by Prasco Laboratories.*
Figure (Teri Um F16 V1)
An instructional illustration showing a hand holding a Teriparatide injection pen. The image depicts removal of the pen's protective cap, indicating preparation for subcutaneous injection.*
Figure (Teri Um F17 V1)
Illustration showing hands holding and preparing a Teriparatide injection pen for subcutaneous use. One hand grips the device while the other removes the cap, indicating the medication is in a prefilled injection pen form.*
Figure (Teri Um F18 V1)
Teriparatide 250 mcg/mL injection solution in a prefilled pen injector. The pen is primarily white and blue with a black end cap. The label area is visible but text on the label is obscured. Manufactured by Prasco Laboratories for subcutaneous use.*
Figure (Teri Um F19 V1)
An instructional illustration showing a hand holding a vial with a red prohibition symbol over it, indicating that the vial should not be held or handled in this manner. This is associated with Teriparatide injection solution for subcutaneous use from Prasco Laboratories.*
Package Label – Teriparatide Injection 20 Mcg Per Dose, 2.4 mL (Teriparatide Carton 20mcg 016 03)
Packaging label for Teriparatide Injection 20 mcg per dose (given once daily subcutaneously), 600 mcg/2.4 mL (250 mcg/mL) solution for injection. The label notes the product is for single-patient use only, refrigerated storage, and subcutaneous administration. It includes usage instructions, warnings, and contact information. Labeler is Prasco Laboratories.*
Teriparatide Amino Acid Sequence (Teriparatide F001 V1)
Chemical structure diagram showing the amino acid sequence of Teriparatide. The sequence is presented as connected circles, each labeled with the standard three-letter abbreviation for an amino acid residue, numbered from 1 to 34.*
Figure 1 (Teriparatide F002 V1)
A line graph comparing the percent of patients with nonvertebral osteoporotic fractures over 20 months since randomization, showing separate curves for Teriparatide and placebo groups. The Y-axis represents the percent of patients, and the X-axis shows months since randomization, with Teriparatide depicted by a dotted line and placebo by a solid line.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
